Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 2:29 pm Purchase | 2022-12-30 | 13G | THE CARLYLE GROUP INC. CG | MORGAN STANLEY MS | 23,412,646 6.400% | 5,188,324 (+28.47%) | Filing History |
| 2023-01-31 4:15 pm Purchase | 2023-01-27 | 13D | JASPER THERAPEUTICS INC JSPR | Carlyle Group, Inc. CG | 876,189 8.000% | 313,333 (+55.67%) | Filing History |
| 2023-01-23 5:15 pm Purchase | 2023-01-12 | 13D | CARLYLE CREDIT INCOME FUND SHS CCIF | Carlyle Group, Inc. CG | 3,718,256 35.800% | 3,718,256 (New Position) | Filing History |
| 2022-12-20 4:30 pm Sale | 2022-12-16 | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group, Inc. CG | 0 0.000% | -1,224,571 (Position Closed) | Filing History |
| 2022-08-29 5:27 pm Purchase | 2022-08-17 | 13G | MKS INC. MKSI | Carlyle Group, Inc. CG | 8,482,732 12.800% | 8,482,732 (New Position) | Filing History |
| 2022-08-11 5:03 pm Purchase | 2022-08-01 | 13D | EXICURE INC XCUR | Carlyle Group, Inc. CG | 57,086 5.700% | 57,086 (New Position) | Filing History |
| 2022-08-11 5:01 pm Purchase | 2022-08-01 | 13D | VERA THERAPEUTICS INC VERA | Carlyle Group, Inc. CG | 2,970,156 11.100% | 2,970,156 (New Position) | Filing History |
| 2022-08-11 5:00 pm Purchase | 2022-08-01 | 13D | ADICET BIO INC ACET | Carlyle Group, Inc. CG | 134,560 5.400% | 134,560 (New Position) | Filing History |
| 2022-08-11 4:58 pm Purchase | 2022-08-01 | 13D | NUCANA PLC SPONSORED ADR RPST NCNA | Carlyle Group, Inc. CG | 671 6.400% | 671 (New Position) | Filing History |
| 2022-08-11 4:56 pm Purchase | 2022-08-01 | 13D | SOLENO THERAPEUTICS INC NE SLNO | Carlyle Group, Inc. CG | 1,224,571 15.300% | 1,224,571 (New Position) | Filing History |
| 2022-08-11 4:55 pm Purchase | 2022-08-01 | 13D | EFFECTOR THERAPEUTICS INC EFTR | Carlyle Group, Inc. CG | 193,196 11.700% | 193,196 (New Position) | Filing History |
| 2022-08-11 4:52 pm Purchase | 2022-08-01 | 13D | RENEO PHARMACEUTICALS INC RPHM | Carlyle Group, Inc. CG | 208,796 8.500% | 208,796 (New Position) | Filing History |
| 2022-08-11 4:50 pm Purchase | 2022-08-01 | 13D | SPRUCE BIOSCIENCES INC SPRB | Carlyle Group, Inc. CG | 24,034 7.700% | 24,034 (New Position) | Filing History |
| 2022-08-11 4:47 pm Purchase | 2022-08-01 | 13D | JASPER THERAPEUTICS INC JSPR | Carlyle Group, Inc. CG | 562,856 15.400% | 562,856 (New Position) | Filing History |
| 2022-07-27 4:31 pm Purchase | 2021-12-31 | 13D | VISTANCE NETWORKS, INC. VISN | Carlyle Group, Inc. CG | 39,468,542 16.000% | 3,104,942 (+8.54%) | Filing History |
| 2022-06-14 4:41 pm Sale | 2022-06-09 | 13D | THE CARLYLE GROUP INC. CG | Carlyle Group Management L.L.C. | 152,131,004 42.100% | -3,724,382 (-2.39%) | Filing History |
| 2022-06-06 5:17 pm Purchase | 2022-05-27 | 13D | QUIDELORTHO CORPORATION QDEL | Carlyle Group, Inc. CG | 12,460,183 18.600% | 12,460,183 (New Position) | Filing History |
| 2022-02-14 2:33 pm Sale | 2021-12-31 | 13G | THE CARLYLE GROUP INC. CG | Vulcan Value Partners, LLC | 16,609,123 4.660% | -8,810,166 (-34.66%) | Filing History |
| 2022-02-11 4:31 pm Sale | 2021-12-31 | 13G | CORESITE REALTY CORPORATION CO | Carlyle Group, Inc. CG | 0 0.000% | -5,875,218 (Position Closed) | Filing History |
| 2022-02-11 4:22 pm Purchase | 2021-12-31 | 13G | ORTHO CLINICAL DIAGNOSTICS HLD OCDX | Carlyle Group, Inc. CG | 118,106,000 49.900% | 118,106,000 (New Position) | Filing History |